The semicarbazide-sensitive amine oxidases (SSAOs) are grouped together under the Enzyme Commission classification, EC 1.4.3.6 [amine: oxygen oxidoreductase (deaminating) (copper containing)] and have a history dating back to the discovery of histaminase by Best in 1929 [l] . This enzyme was subsequently renamed diamine oxidase (DAO), to help establish its separate identity from monoamine oxidase (EC 1.4.3.4; MAO). Doubts about this terminology were expressed when it was shown that some long chain diamines were substrates for MA0 and not DAO, while other enzyme activities capable of deaminating mono-, diand polyamines were beginning to appear (see [2] for review). This led Blaschko [3] to introduce terminology based on the sensitivity of a particular amine oxidase to carbonyl reagents such as semicarbazide and hydroxylamine. One group contained 'enzymes resistant to inhibition by carbonyl groups' and included the classical MA0 enzymes as well as a number of other FAD-dependent enzymes. The other group contained 'enzymes inhibited by carbony1 reagents'. Its members included DAO and enzymes in plants and bacteria as well as enzymes in blood plasma that were capable of deaminating monoamines such as benzylamine and ruminant ~ ____ Abbreviations used: AA, allylamine (3-aminopropene); ACR, acrolein (prop-1-en-3-one); B24, 3,5-ethoxy-4-aminomethylpyridine,ZHCl; DAO, diamine oxidase; EDRF, endothelium-derived relaxing factor; MAO, monoamine oxidase; MDL 72 145, (E)-2-( 3',4'-dimethoxyphenyl)-3-fluoroallylamine; PCZ, N-isopropyl-a-(Zmethylhydrazin0)-p-toluamide. HCI (procarbazine); PQQ. pyrroloquinoline quinone; SSAO, semicarbazidesensitive amine oxidase; GSH, reduced glutathione. *To whom correspondence should be addressed. that 'carbonyl reagent' should be replaced by 'semicarbazide' since some carbonyl reagents were also active against the first group of enzymes while semicarbazide was not. Since the introduction of this classification, a number of additions have been made and the name SSAO has gained in acceptance. Such additions include lysyl oxidase (proteinlysine 6-oxidase; EC 1.4.3.13) [6] and an assortment of tissue-bound amine oxidases found mainly in brown and white fat as well as smooth muscles, especially those of blood vessels. The SSAO group appears to grow inexorably and, as yet, the great majority of its constituent enzymes have no rigorously defined name. Several trivial names have been used to describe both these tissue-bound and the plasma enzymes, including benzylamine oxidase and clorgyline-resistant amine oxidase [ 41.
However, SSAO appears to be the most suitable name at present since the criterion for an enzyme to be included in this group is that its .ability to catalyse oxidative deamination is inhibited by semicarbazide. No other characteristic is required for inclusion.
SSAO, like MAO, catalyses a double-displacement, or ping-pong reaction, although it would appear to be of the aminotransferase type: 
Possible functions of plasma SSAO
Little is known of the physiological functions of plasma SSAO enzymes although, in herbivores, the ability to deaminate spermine and spermidine has been put forwai rl to justify a possible scavenging role to protect the animals from these polyamines produced from cellulose fermentation. In support is the observation that the development of the rumen both phylogenetically and in the young animal is accompanied by the development of this deaminating ability in the plasma [15] . Against this is the observation in goats that SSAO still appeared even when the development of the rumen was prevented [ 161. In addition some of the products of deamination, the aminoaldehydes, NH, and H,O, could be more toxic than the amine substrates themselves [17] [18] [19] . An interesting endogenous amine in this context is methylamine [ 131, which has been shown to be deaminated by plasma SSAO, with a K, of 5 16 ,UM [20] , presumably to formaldehyde. Clearly, the relative rates of formation and further metabolism of the formaldehyde will be important.
Even if the physiological function of plasma SSAO remains elusive, its activity does not remain constant either in man or ruminant. Recently, we have found that diabetes in Welsh Mountain ewes causes the SSAO activity to rise, while in pregnancy the activity remains unchanged until the final month before lambing when it falls by 50% [21] . It is possible that, at this time, the growing fetal lambs are competing with the ewe for dietary copper. Changes in plasma SSAO activity might therefore be used as an indicator of the copper status of the animals and, indeed, of the flock in general. This competition for copper may be the reason why, in human subjects, plasma SSAO activity falls sharply in burned patients as well as in those afflicted with solid cell tumours [ZZ] .
While the main function of SSAO could be the deamination of an endogenous substrate, it is also possible that the enzyme serves a function similar to that of the microsomal drug-metabolizing enzymes of the liver. Like them it may not always detoxify its substrates but could lead to an increase in their toxicity (see below). Any further functions of plasma SSAO enzymes remain enigmatic. A further complication follows from the observation that two plasma SSAO enzymes are to be found in, for example, the sheep and horse, with different activities towards spermine and spermidine [23] . It is to be hoped that these do not turn out to be a vestige of times past.
Tissue-bound SSAO
The close association of tissue-bound SSAO with the circulation, and in particular with smooth muscle cells of blood vessels, makes this enzyme ideally situated to scavenge circulating amines. A good example of this possibility is the deamination of methylamine observed in human umbilical artery [20] . It is known that methylamine is cytotoxic and can inhibit insulin release as well as disrupt intracellular processing and the recycling of certain plasma membrane receptors [ 131. The k,, for the deamination of methylamine is 709 h -' by homogenates of human umbilical artery while, for benzylamine, it is 1698 h-'. However, the K , for methylamine is high (832 PM) but the enzyme may help to protect the mother against high concentrations of toxic amines produced as a result of the rapid growth of the fetus.
Evidence This suggests that SSAO located on the plasmalemma could affect cellular responses to agonists. In the isolated, perfused mesenteric arterial bed of the rat some evidence has been obtained which may indicate that the SSAO in the vascular smooth muscle does have such a function [29] . If benzylamine is perfused through the preparation at the same time as adrenaline, the dose-response curve is shifted to the left. If SSAO is selectively inhibited with MDL 72145 [(E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine], this shift is increased indicating that the benzylamine effect is due to the amine itself and not to the products of its deamination. A similar experiment may also be carried out to examine the relaxing effect of carbachol, which exerts its action by the release of endotheliumderived relaxing factor (EDRF), by co-administering it with adrenaline. In this case, the effect of benzylamine is to shift the carbachol curve to the left and to decrease the Hill coefficient, i.e. a greater effect with lower doses of carbachol than with higher doses. This effect of benzylamine was completely prevented by inhibition of SSAO with MDL 72145. Thus this action on carbachol was due to the metabolites of benzylamine and not to the amine itself.
Any interaction between the products generated by SSAO and the EDRF responses measured in these experiments could be due to an interaction at the level of EDRF production and release, a chemical interaction with EDRF, or an interaction at the level of the smooth muscle cell influencing the mechanisms involved in EDRFinduced relaxation. Strong evidence has accumulated that the relaxing factor released into the lumen of blood vessels by agonists which cause endothelium-dependent relaxations is nitric oxide, or a compound closely related to it, which is formed from the terminal guanido atoms of L-arginine [ 301.
The exact reaction pathway which results in release of nitric oxide is not known. In the mouse macrophage, an L-arginine deiminase which liberates ammonia and is then oxidized to NO, and NO3 has been postulated [ 3 11. An increase in the availability of ammonia, from the deamination of benzylamine by SSAO, for the synthesis of EDRF could be the explanation for the potentiation of the action of carbachol by benzylamine in the perfused mesenteric arterial bed.
SSAO enzymes and xenobiotics
Not only endogenous amines could be converted into toxic metabolites by plasma and tissue-bound SSAO enzymes but also exogenous amines. Suitable substrates might gain access to the enzymes in many ways, such as through the clinical use of drugs or as inhaled or assimilated industrial or environmental agents.
Allylamine (AA, 3-aminopropene) is an extremely reactive alkylamine, used industrially in the manufacture of pharmaceuticals, rubber and polymer plastics. Highly selective cardiovascular toxicity has been demonstrated for AA in a number of laboratory animals, whether administered intravenously, in drinking water or by inhalation [32] . The pathological effects of chronic AA exposure appear to involve predominantly the heart, aorta and coronary arteries. Typically, these include acute myocardial necrosis and intimal proliferation of smooth muscle in the aorta and coronary arteries, leading to transmural scarring with ventricular aneurysm formation and endocardia1 cartilagenous metaplasia with calcification [ 321. Endothelial cell proliferation in the rat heart is accompanied by a Volume 19 parallel increase in mitotic activity [33] . The demonstration that inhibitors of SSAO can prevent such damage occurring both in vivo [34] and in vitro [35, 36] suggests that damage is due not to AA itself, but to the actions of an oxidized metabolite. The primary candidate for such a compound is the aldehyde acrolein (ACR, prop-1-en-3-one) .
ACR is an extremely reactive a,p-unsaturated aldehyde which is found in cigarette smoke and is a toxic metabolite of some anti-tumour drugs [37] . It is conjugated with reduced glutathione (GSH) in vivo and is excreted in the urine of rats as the mercapturic acid, S-( 3-hydroxypropyl)-~-cysteine [38] . The conversion in vitro of AA to ACR by cardiovascular tissue homogenates [ 391 and by purified porcine SSAO [36] can be prevented by prior administration of selective SSAO inhibitors. Furthermore, AA is selectively toxic to cultured porcine aortic smooth muscle cells when compared with endothelial and fibroblastic cells [40] , SSAO inhibitors decreasing endothelial cell lysis and increasing viability as measured by the influx of the dye, erythrosin B [35] . Similar studies using cultured myocytes from neonatal rat heart show ACR to be at least as potent as AA in causing cell lysis, with semicarbazide, but not clorgyline, preventing AA-induced damage. Neither inhibitor could protect against lysis caused by ACR [41] .
The close association of AA toxicity with SSAO activity can explain the susceptibility of cardiovascular tissues to injury by ACR, since vascular smooth muscle has been shown to be a major source of SSAO in a number of species, including the rat [42] and human subjects [43] . However cytotoxic events at the subcellular level, which lead both to the sublethal and lytic injuries seen in culured cells and to the gross pathological lesions seen in tissues and organs in vivo, remain something of a mystery. The localized depletion of GSH due to ACR conjugation could result in a reduced protective capacity against lipid peroxidation either by vitamin E radicals themselves or by other unconjugated radicals, both of which would be present at higher levels than usual due to the inability of GSH-dependent free radical reductase to regenerate vitamin E. Alkylation by ACR of thiol groups on enzymes controlling these scavenging mechanisms might modulate their activity such that protection is further reduced [44] .
It is known however, that AA is both a substrate and a suicide inhibitor of MAO, with benzylamine-induced reactivation of the enzyme resulting in ACR release [45] . AA has been shown to cause derangements in vivo of cardiac MA0 which are proportional to the histopathological severity of cardiac lesions [34] . Radioactivity can be located at specific sites in mitochondria isolated from rat hearts and aortae after incubation with ['4C]AA, although it is unclear whether AA has been metabolized to ACR before binding [46] . ACR is a potent inhibitor of rat liver mitochondrial glutamate transport, inorganic phosphate transport and SUCcinate dehydrogenase activity [47] , and both AA and ACR weakly inhibit rat heart mitochondrial electron transport [48] . Such findings have therefore led some workers to suggest that mitochondria might be the subcellular site for AA injury to cardiovascular tissues.
Selective inhibitors of SSAO
Investigations into the possible functions of SSAO enzymes, both in vivo and preparations of organs in m*tm have been greatly hampered by the lack of highly selective inhibitors. On the whole the search for such inhibitors, until recently, has not been very successful [4] . While the antihypertensive agent hydralazine has been used to determine the subunit M, of the SSAO of rat brown adipose tissue [49] , it binds to far too many other cell constituents to be employed in vivo. The compound, MDL 72145 [SO], while working well in tissues that only contain MAO-A and SSAO [29] , cannot be used in the presence of MAO-B.
Recently the 4-picolylamine derivative, B24 (3,S-et hoxy-Caminornet hylp yridine .2HC1) has been found to be a highly selective, reversible inhibitor of SSAO [51] . The compound would seem also to be a substrate for plasma-borne, but not tissue-bound, SSAO, and displays non-competitive kinetics. This may well turn out to be an important addition to the collection of SSAO inhibitors. However, there is a real need for an irreversible inhibitor, which could be used in vivo. In an attempt to overcome this problem we have recently examined the anti-cancer agent N-isopropyl-a-(2-methylhydrazino)-p-toluamide.HC1 (PCZ) as a selective inhibitor of SSAO. It was Lewinsohn and her colleagues [52] who first demonstrated that PCZ was an inhibitor of SSAO in various human tissues, displaying a potency greater than compounds such as semicarbazide and benserazide. With SSAO from the interscapular brown adipose tissue of the rat we have shown that, with PCZ, the degree of inhibition depended upon the period of preincubation of enzyme and inhibitor before the addition of benzylamine as substrate. However, at present, it is not possible to state that the enzyme inhibition is due to the PCZ itself or to a metabolic product. There is no doubt however, that this compound represents a new approach to the study of SSAO enzymes since its selectivity is much greater than those that have gone before, possessing only a very small activity towards M A 0 [53].
It now seems safe to believe that SSAO enzymes could have a real function to perform in vivo. As yet, these fairly tentative suggestions lack really rigorous testing procedures. The fact that the activity of sheep and human plasma SSAO can change under a variety of circumstances may prove to be important, as could be the ability of SSAO enzymes to metabolize xenobiotics. The use of really selective inhibitors that can be employed even in the presence of competing enzymes should help to decide the value of SSAO enzymes in the living animal.
